Incyte Corp (INCY) financials

Incyte Corp (INCY) revenue, EBIT and EBITDA, earnings per share, free cash flow, margins, debt and shareholders equity — annual and quarterly history, charted from SEC filings. No account needed.

In fiscal 2025, Incyte Corp reported revenue of $5.14B, up 21.2% year over year, net income of $1.29B and diluted EPS of $6.41.

Revenue (fiscal 2025)

$5.14B

Revenue growth (fiscal 2025)

21.2%

Net income (fiscal 2025)

$1.29B

Diluted EPS (fiscal 2025)

$6.41

Incyte Corp files with the U.S. Securities and Exchange Commission under CIK 0000879169, classified as Services-Commercial Physical & Biological Research.

Explore annual and quarterly revenue, earnings, cash flow, margins, debt and equity from SEC filings.